|

M7824 Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 1/2: 2

Top Sponsors

  • National Cancer Institute (NCI)3

Indications

  • Cancer3
  • Prostate Neoplasms1
  • Urogenital Neoplasms1
  • Kaposi Sarcoma1
  • Genitourinary Cancer1

Bethesda, Maryland3 trials

A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

National Institutes of Health Clinical Center

Phase 1/2
Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

National Institutes of Health Clinical Center

Phase 1
PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

National Institutes of Health Clinical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.